Literature DB >> 19190339

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

Emmanuelle Charafe-Jauffret1, Christophe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, Pascal Finetti, Min-Hee Hur, Mark E Diebel, Florence Monville, Julie Dutcher, Marty Brown, Patrice Viens, Luc Xerri, François Bertucci, Giorgio Stassi, Gabriela Dontu, Daniel Birnbaum, Max S Wicha.   

Abstract

Tumors may be initiated and maintained by a cellular subcomponent that displays stem cell properties. We have used the expression of aldehyde dehydrogenase as assessed by the ALDEFLUOR assay to isolate and characterize cancer stem cell (CSC) populations in 33 cell lines derived from normal and malignant mammary tissue. Twenty-three of the 33 cell lines contained an ALDEFLUOR-positive population that displayed stem cell properties in vitro and in NOD/SCID xenografts. Gene expression profiling identified a 413-gene CSC profile that included genes known to play a role in stem cell function, as well as genes such as CXCR1/IL-8RA not previously known to play such a role. Recombinant interleukin-8 (IL-8) increased mammosphere formation and the ALDEFLUOR-positive population in breast cancer cell lines. Finally, we show that ALDEFLUOR-positive cells are responsible for mediating metastasis. These studies confirm the hierarchical organization of immortalized cell lines, establish techniques that can facilitate the characterization of regulatory pathways of CSCs, and identify potential stem cell markers and therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190339      PMCID: PMC2819227          DOI: 10.1158/0008-5472.CAN-08-2741

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters.

Authors:  Federica Montanaro; Kalliopi Liadaki; Jaclyn Schienda; Alan Flint; Emanuela Gussoni; Louis M Kunkel
Journal:  Exp Cell Res       Date:  2004-08-01       Impact factor: 3.905

2.  Gene expression profiling of breast cell lines identifies potential new basal markers.

Authors:  E Charafe-Jauffret; C Ginestier; F Monville; P Finetti; J Adélaïde; N Cervera; S Fekairi; L Xerri; J Jacquemier; D Birnbaum; F Bertucci
Journal:  Oncogene       Date:  2006-04-06       Impact factor: 9.867

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Ott1(Rbm15) has pleiotropic roles in hematopoietic development.

Authors:  Glen D Raffel; Thomas Mercher; Hirokazu Shigematsu; Ifor R Williams; Dana E Cullen; Koichi Akashi; Olivier A Bernard; D Gary Gilliland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

5.  Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer.

Authors:  Catherine Murphy; Maryalice McGurk; Johanna Pettigrew; Alfredo Santinelli; Roberta Mazzucchelli; Patrick G Johnston; Rodolfo Montironi; David J J Waugh
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

6.  Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

Authors:  Gennadi V Glinsky; Olga Berezovska; Anna B Glinskii
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

7.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  IL-6 involvement in epithelial cancers.

Authors:  Zachary T Schafer; Joan S Brugge
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.

Authors:  P J Maxwell; R Gallagher; A Seaton; C Wilson; P Scullin; J Pettigrew; I J Stratford; K J Williams; P G Johnston; D J J Waugh
Journal:  Oncogene       Date:  2007-05-28       Impact factor: 9.867

View more
  546 in total

1.  Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.

Authors:  Qiao Zheng; Sarah M Dunlap; Jinling Zhu; Erinn Downs-Kelly; Jeremy Rich; Stephen D Hursting; Nathan A Berger; Ofer Reizes
Journal:  Endocr Relat Cancer       Date:  2011-07-11       Impact factor: 5.678

2.  Controversies in cancer stem cells: targeting embryonic signaling pathways.

Authors:  Naoko Takebe; S Percy Ivy
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 3.  Prostate cancer stem cell biology.

Authors:  C Yu; Z Yao; Y Jiang; E T Keller
Journal:  Minerva Urol Nefrol       Date:  2012-03       Impact factor: 3.720

Review 4.  Cancer stem cell hypotheses: impact on modern molecular physiology and pharmacology research.

Authors:  Igor Pantic
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

5.  The biology of incipient, pre-invasive or intraepithelial neoplasia.

Authors:  William E Grizzle; Sudhir Srivastava; Upender Manne
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 6.  Gene polymorphisms: the keys for marker assisted selection and unraveling core regulatory pathways for mastitis resistance.

Authors:  Gina M Pighetti; A A Elliott
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-14       Impact factor: 2.673

7.  Cancer stem cells: nature versus nurture.

Authors:  Hasan Korkaya; Max S Wicha
Journal:  Nat Cell Biol       Date:  2010-04-25       Impact factor: 28.824

Review 8.  Targeting breast cancer stem cells.

Authors:  Suling Liu; Max S Wicha
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

Review 9.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 10.  Circulating tumor cells: from bench to bedside.

Authors:  Marija Balic; Anthony Williams; Henry Lin; Ram Datar; Richard J Cote
Journal:  Annu Rev Med       Date:  2012-10-18       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.